Who is sponsoring NCT03371212?

NCT03371212 is sponsored by Rush University Medical Center.

What drugs are being tested in NCT03371212?

Interventions in NCT03371212: Dual mobility cohort, Conventional cohort.

What condition does NCT03371212 study?

NCT03371212 studies Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium.

Is NCT03371212 still recruiting?

NCT03371212 is currently active, enrolled. Last updated 8 January 2026.

Last reviewed 2026-01-08 · How we verify

NCT03371212

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Prospective Randomized Controlled Trial of Dual-Mobility Components in Primary THA

Active, enrolled Phase 4 Last updated 8 January 2026

What this trial tests

Phase 4 trial testing Dual mobility cohort in Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium in 52 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

15 December 2017

Primary endpoint
1 December 2035

1 December 2036

Quick facts

Lead sponsor	Rush University Medical Center
Phase	Phase 4
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	52
Start date	15 December 2017
Primary completion	1 December 2035
Estimated completion	1 December 2036
Sites	1 location across United States

Drugs / interventions tested

Dual mobility cohort
Conventional cohort

Conditions studied

Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium — all drugs for Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium →

Sponsor

Rush University Medical Center

Who can join

Adults 18 to 80, any sex, with Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine if the use of a modular dual mobility bearing is associated with clinically important increases in serum metal levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Rush University Medical Center trials

Trials by the same sponsor.

NCT07278076 — Clinical Decision-Making During FEES: The Impact of Residue Amount and Location · NA · not yet recruiting
NCT07088120 — PRECISION-CPR: PRecision-Controlled Ventilation in CPR · NA · not yet recruiting
NCT06894719 — Oral Tranexamic Acid After Total Knee Arthroplasty · Phase 4 · not yet recruiting
NCT06229392 — A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer · Phase 1 · withdrawn
NCT07452406 — Protocolized Weaning of High-Flow Nasal Cannula in Adult Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03371212 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rush University Medical Center
Last refreshed: 8 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03371212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing